Shineco Subsidiary Receives Marketing Approval from China’s Regulatory Body for its Cardiac 5-Minute Test
10 juil. 2023 09h00 HE
|
Shineco, Inc.
Registration with the NMPA, China’s Regulatory Equivalent to the FDA, is a Prerequisite to Marketing and Distribution BEIJING, July 10, 2023 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the...
Shineco, Inc. Attends MEDICA 2022 Düsseldorf Germany
29 nov. 2022 09h00 HE
|
Shineco, Inc.
BEIJING, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a producer and distributor of Chinese herbal medicines, organic agricultural and other biotech...